Gilead Sciences(GILD)
Gilead Sciences, Inc. (/ˈɡɪliəd/) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Atripla | Efavirenz, Emtricitabine, Tenofovir disoproxil | 2006-07-12 | 2024-2038 | |
| Biktarvy | Bictegravir, Emtricitabine, Tenofovir alafenamide | 2018-02-07 | 2024-2038 | |
| Cayston | Aztreonam | 2010-02-22 | ||
| Complera | Emtricitabine, Rilpivirine, Tenofovir disoproxil | 2011-08-10 | 2024-2038 | |
| Descovy | Emtricitabine, Tenofovir alafenamide | 2016-04-04 | 2024-2038 | |
| Emtriva | Emtricitabine | 2003-07-02 | 2024-2038 | |
| Epclusa | Sofosbuvir, Velpatasvir | 2016-06-28 | 2028-2037 |
1
2
3
4
5
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
15
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use